{"calculatePct":false,"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"groups":[{"description":"Participants newly diagnosed with MM within 3 months from initiation of treatment were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).","id":"OG000","title":"NDMM"},{"description":"Participants diagnosed with RRMM who previously received 1 to 3 prior lines of therapy were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).","id":"OG001","title":"RRMM"}],"populationDescription":"As the study was early terminated data was not collected for this outcome measure.","reportingStatus":"POSTED","timeFrame":"Baseline up to 5 years","title":"Number of Participants Diagnosed With Symptoms of ND MM and R/R MM During the Study","type":"PRIMARY"}